close

Enter

Log in using OpenID

At Home Diagnostics Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026

embed
At home diagnostics market is calculated to value over US$ 6 billion the end of 2026 and register at a CAGR of over 3% during the forecast period of 2019-2026.
At Home Diagnostics Market Global Trends, Market Share, Industry Size, Growth,
Opportunities, and Market Forecast 2019 to 2026
At home diagnostics market is calculated to value over US$ 6 billion the end of 2026
and register at a CAGR of over 3% during the forecast period of 2019-2026.
Home Diagnostics are tests which are performed on samples which are collected
from the human body. The samples include urine, blood and saliva. Home
Diagnostics is also known as vitro diagnostics and is used to detect medical
conditions or diseases at home without the help of any professional medical. The
distinctness and accurateness of these tests play a significant role in the performance
of home diagnostics. Home diagnostics are commonly available in the form of
cassettes, strips, digital monitoring instruments, cups, and dip cards.
Increase in the epidemic diseases has made the general population turn their
attention towards curative medicines which have led to the growth of the market.
Increasing per capita healthcare expenditure because of the increase in the standard
of living has led to the huge growth of the market. Aggressive online marketing and
promotional strategies online have further fuelled the market. Manufacturers are
using the online market to endorse the products and it's been effective in providing
growth of home diagnostics. Widespread in technology and growth in the geriatric
population have further fuelled the market. However, low health awareness in
developing nations like India, Middle East and African countries is proving to be a
restraint for the development of the market. Also, high cost is required for upgrading
the product and production which also acts as a restraint.
North America and Europe dominated the global market due to high awareness
among the general population. In North America, the US holds 90% market share
because of high adoption. In Europe, France, Germany and UK control the global
market due to high penetration among the general population. The Asia Pacific and
Latin America is the most opportunistic market for manufacturers due to the large
patient population. They both are expected to witness high growth rate during the
forecast period. Rest of the World accounts the small fraction of the market and it is
expected to account more share during the later phase of the forecast period.
Request a Sample Report @ https://www.futurewiseresearch.com/requestsample.aspx?id=181&page=requestsample
Home Diagnostics Market Restraints
• Low health awareness in developing countries
• High cost required for production and product upgrade
Home Diagnostics Market Segmentation
By Application:
• Allergy Detection
•
•
•
•
Fertility test
Infectious testing
Cholesterol testing
Others
By Distribution Channel:
• Retail Pharmacies
• Institutional Distribution
• Online Pharmacies
By Region:
• North America
• Latin America
• Europe
• Asia-Pacific
• Rest of the World
Purchase a Copy of this Premium Research Report & Ask For Discount:
https://www.futurewiseresearch.com/requestsample.aspx?id=181&page=askfordiscount
Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants
Futurewise Key Takeaways
• Growth Prospects
• SWOT Analysis
• Key Trends
• Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global at home diagnostics market
by application, by distribution channel, and by region
• To cater comprehensive information on factors impacting market growth (drivers,
restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)—North America,
Europe, Asia Pacific, Latin America, and the Middle East.
• To record evaluate and competitive landscape mapping- product launches,
technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financial and
core competencies
Table of Contents
1.1. Introduction
1.1.1.1. Scope and Objective
1.1.1.2. Assumptions and Acronyms
1.1.1.3. Forecast Factors
1.1.1.4. Research Methodology
1.2. Executive Summary
1.2.1.1. Industry Cluster Analysis
1.2.1.2. Competition Matrix
1.2.1.3. Strategies Recommendations
1.3. Market Definition
1.3.1.1. Report Scope (Inclusions & Exclusions)
1.3.1.2. Market Segmentation
1.4. Global At Home Diagnostics Market Overview
1.4.1.1. Global At Home Diagnostics Market Revenue (USD Mn)
1.5. Key Inclusions
1.5.1.1. Porter’s Five Force analysis
1.5.1.2. Market Dynamics
1.5.1.3. Industry Trends
1.5.1.4. Regulatory Guidelines
1.5.1.5. Opportunities in At Home Diagnostics
1.6. Competition Dynamics
1.6.1.1. Company Share Analysis (2018)
1.6.1.2. Top 10 Product Pricing by Region
1.7. Global At Home Diagnostics Market Revenue (USD Mn), 2018-2026 by
Application
1.7.1.1. Key Market Findings
1.7.1.2. Long Term ROI Segments
1.7.1.3. Revenue Opportunity Influencing Factors
1.7.1.4. Market Revenue (USD Mn) Assessment and Forecast by
Application, 2018-2026
1.7.1.4.1.1.
Allergy Detection
1.7.1.4.1.2.
Fertility Testing
1.7.1.4.1.3.
Infectious Diseases
1.7.1.4.1.4.
Cholesterol Testing
1.7.1.4.1.5.
Others
1.8. Global At Home Diagnostics Market Revenue (USD Mn), 2018-2026 by
Distribution Channel
1.8.1.1. Key Market Findings
1.8.1.2. Long Term ROI Segments
1.8.1.3. Revenue Opportunity Influencing Factors
1.8.1.4. Market Revenue (USD Mn) Assessment and Forecast by
Distribution Channel, 2018-2026
1.8.1.4.1.1.
Retail Pharmacies
1.8.1.4.1.2.
Institutional Distribution
1.8.1.4.1.3.
Online Pharmacies
1.9. Global At Home Diagnostics Market Revenue (USD Mn), 2018-2026 by
Region
1.9.1.1. Key Market Findings
1.9.1.2. Long Term ROI Segments
1.9.1.3. Revenue Opportunity Influencing Factors
1.9.1.4. Market Revenue (USD Mn) Assessment and Forecast by
Region,2026
1.9.1.4.1.1.
North America
1.9.1.4.1.2.
Latin America
1.9.1.4.1.3.
Europe
1.9.1.4.1.4.
Asia Pacific
1.9.1.4.1.5.
Rest of world
1.10.
North America At Home Diagnostics Market Revenue (US$ Mn), 20182026
1.10.1.1. Key Market Findings
1.10.1.2. Long Term ROI Segments
1.10.1.3. Revenue Opportunity Influencing Factors
1.10.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.10.1.4.1.1.
US
1.10.1.4.1.2.
Canada
1.10.1.5. Market Revenue (USD Mn) Assessment and Forecast by
Application, 2018-2026
1.10.1.5.1.1.
Allergy Detection
1.10.1.5.1.2.
Fertility Testing
1.10.1.5.1.3.
Infectious Diseases
1.10.1.5.1.4.
Cholesterol Testing
1.10.1.5.1.5.
Others
1.10.1.6. Market Revenue (USD Mn) Assessment and Forecast by
Distribution Channel, 2018-2026
1.10.1.6.1.1.
Retail Pharmacies
1.10.1.6.1.2.
Institutional Distribution
1.10.1.6.1.2.1.
Online Pharmacies
1.11.
Latin America At Home Diagnostics Market Revenue (US$ Mn), 20182026
1.11.1.1. Key Market Findings
1.11.1.2. Long Term ROI Segments
1.11.1.3. Revenue Opportunity Influencing Factors
1.11.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.11.1.4.1.1.
Brazil
1.11.1.4.1.2.
Mexico
1.11.1.4.1.3.
Argentina
1.11.1.4.1.4.
Rest of Latin America
1.11.1.5. Market Revenue (USD Mn) Assessment and Forecast by
Application, 2018-2026
1.11.1.5.1.1.
Allergy Detection
1.11.1.5.1.2.
Fertility Testing
1.11.1.5.1.3.
Infectious Diseases
1.11.1.5.1.4.
Cholesterol Testing
1.11.1.5.1.5.
Others
1.11.1.6. Market Revenue (USD Mn) Assessment and Forecast by
Distribution Channel, 2018-2026
1.11.1.6.1.1.1.
Retail Pharmacies
1.11.1.6.1.1.2.
Institutional Distribution
1.11.1.6.1.1.3.
Online Pharmacies
1.12.
Europe America At Home Diagnostics Market Revenue (US$ Mn),
2018-2026
1.12.1.1. Key Market Findings
1.12.1.2. Long Term ROI Segments
1.12.1.3. Revenue Opportunity Influencing Factors
1.12.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.12.1.4.1.1.
Germany
1.12.1.4.1.2.
France
1.12.1.4.1.3.
Spain
1.12.1.4.1.4.
UK
1.12.1.4.1.5.
Russia
1.12.1.4.1.6.
Poland
1.12.1.4.1.7.
Rest of Europe
1.12.1.5. Market Revenue (USD Mn) Assessment and Forecast by
Application, 2018-2026
1.12.1.5.1.1.
Allergy Detection
1.12.1.5.1.2.
Fertility Testing
1.12.1.5.1.2.1.
Infectious Diseases
1.12.1.5.1.2.2.
Cholesterol Testing
1.12.1.5.1.2.3.
Others
1.12.1.6. Market Revenue (USD Mn) Assessment and Forecast by
Distribution Channel, 2018-2026
1.12.1.6.1.1.1.
Retail Pharmacies
1.12.1.6.1.1.2.
Institutional Distribution
1.12.1.6.1.1.3.
Online Pharmacies
1.13.
Asia Pacific America At Home Diagnostics Market Revenue (US$ Mn),
2018-2026
1.13.1.1. Key Market Findings
1.13.1.2. Long Term ROI Segments
1.13.1.3. Revenue Opportunity Influencing Factors
1.13.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.13.1.4.1.1.
Emerging Asia
1.13.1.4.1.1.1.1. China
1.13.1.4.1.1.1.2. India
1.13.1.4.1.1.1.3. ASEAN-5
1.13.1.4.1.1.1.4. Rest of Emerging Asia
1.13.1.4.1.2.
Japan
1.13.1.5. Market Revenue (USD Mn) Assessment and Forecast by
Application, 2018-2026
1.13.1.5.1.1.
Allergy Detection
1.13.1.5.1.2.
Fertility Testing
1.13.1.5.1.3.
Infectious Diseases
1.13.1.5.1.4.
Cholesterol Testing
1.13.1.5.1.5.
Others
1.13.1.6. Market Revenue (USD Mn) Assessment and Forecast by
Distribution Channel, 2018-2026
1.13.1.6.1.1.
Retail Pharmacies
1.13.1.6.1.2.
Institutional Distribution
1.13.1.6.1.2.1.
Online Pharmacies
1.14.
Rest of World America At Home Diagnostics Market Revenue (US$
Mn), 2018-2026
1.14.1.1. Key Market Findings
1.14.1.2. Long Term ROI Segments
1.14.1.3. Revenue Opportunity Influencing Factors
1.14.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.14.1.4.1.1.
Middle East
1.14.1.4.1.2.
South Africa
1.14.1.4.1.3.
North Africa
1.14.1.4.1.4.
Rest of World
1.14.1.5. Market Revenue (USD Mn) Assessment and Forecast by
Application, 2018-2026
1.14.1.5.1.1.
Allergy Detection
1.14.1.5.1.2.
Fertility Testing
1.14.1.5.1.3.
Infectious Diseases
1.14.1.5.1.4.
Cholesterol Testing
1.14.1.5.1.5.
Others
1.14.1.6. Market Revenue (USD Mn) Assessment and Forecast by
Distribution Channel, 2018-2026
1.14.1.6.1.1.1.
Retail Pharmacies
1.14.1.6.1.1.2.
Institutional Distribution
1.14.1.6.1.1.3.
Online Pharmacies
1.15.
Company Profiles
1.15.1.1. Competition Landscape
1.15.1.2. Global Company Share (USD Mn) Overview, 2018
1.15.1.3. Company Profiles
1.15.1.3.1.1.
Thermo Fisher Scientific
1.15.1.3.1.1.1.1. Corporate Overview
1.15.1.3.1.1.1.2. Financial Performance
1.15.1.3.1.1.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.1.1.4. Company Strategy & Channel Management
1.15.1.3.1.2.
SYNLAB
1.15.1.3.1.2.1.1. Corporate Overview
1.15.1.3.1.2.1.2. Financial Performance
1.15.1.3.1.2.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.2.1.4. Company Strategy & Channel Management
1.15.1.3.1.3.
Siemens Healthcare Private Limited
1.15.1.3.1.3.1.1. Corporate Overview
1.15.1.3.1.3.1.2. Financial Performance
1.15.1.3.1.3.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.3.1.4. Company Strategy & Channel Management
1.15.1.3.1.4.
Roche Diagnostics
1.15.1.3.1.4.1.1. Corporate Overview
1.15.1.3.1.4.1.2. Financial Performance
1.15.1.3.1.4.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.4.1.4. Company Strategy & Channel Management
1.15.1.3.1.5.
Drägerwerk AG & Co. KGaA
1.15.1.3.1.5.1.1. Corporate Overview
1.15.1.3.1.5.1.2. Financial Performance
1.15.1.3.1.5.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.5.1.4. Company Strategy & Channel Management
1.15.1.3.1.6.
Beckman Coulter, Inc.
1.15.1.3.1.6.1.1. Corporate Overview
1.15.1.3.1.6.1.2. Financial Performance
1.15.1.3.1.6.1.3. Peer Comparison & 3C marketing equation
1.16.
1.15.1.3.1.6.1.4. Company Strategy & Channel Management
1.15.1.3.1.7.
Abbott Laboratories
1.15.1.3.1.7.1.1. Corporate Overview
1.15.1.3.1.7.1.2. Financial Performance
1.15.1.3.1.7.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.7.1.4. Company Strategy & Channel Management
Research Sources & Primary Verbatim
Inquire further details about this report at: [email protected]
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and
customised solutions for our clients. Through in-depth market insights and
consultancy, we present our clients with the tools they need to be at the forefront of
their industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
Author
Merin John
Merin John263   documents Email
Document
Category
Health and Medicine
Views
2
File Size
20 KB
Tags
homes
1/--pages
Report inappropriate content